About this trial
Medication adherence is a poorly studied phenomenon that challenges both patients and physicians. 50% of individuals with chronic disease are not adherent to their medication regimen. Within the United States, non-adherence to medical treatment leads to approximately $100 billion in hospital admission costs. While the issue of adherence is not limited to any particular field of medicine, non-adherence occurs in approximately one-third to one-half of dermatological patients. Non-adherence is of importance as it is a significant cause of treatment failure, resulting in worse quality of life, worse health outcomes, and increased insurance costs.
Eligibility criteria
Qualifiers
Diagnosis of skin dermatitis
Age > 9
Ability to return for a one-week clinical studies follow-up
Patients who are candidates for treatment with 0.1% triamcinolone ointment (even if they weren't in the study)
Disqualifiers
Patients without the diagnosis of skin dermatitis
Inability to return for a one week follow up appointment
Body Surface Area (BSA) affected <2%
Trial design
Treatments tested in this trial
- Demonstration of applying triamcinolone cream
- Mobile App Use
- Standard of Care